documents: FDA-2022-N-2390-0057
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-2390-0057 | FDA | FDA-2022-N-2390 | Letter from FDA CDER to Levenson | Supporting & Related Material | Background Material | 2024-11-07T05:00:00Z | 2024 | 11 | 2024-11-07T18:20:10Z | 0 | 0 | 09000064867f5634 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref